These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20839388)

  • 1. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health.
    Wong BS; Rao AS; Camilleri M; Manabe N; McKinzie S; Busciglio I; Burton DD; Ryks M; Zinsmeister AR
    Aliment Pharmacol Ther; 2010 Oct; 32(7):884-93. PubMed ID: 20839388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naloxegol on whole gut transit in opioid-naïve healthy subjects receiving codeine: A randomized, controlled trial.
    Halawi H; Vijayvargiya P; Busciglio I; Oduyebo I; Khemani D; Ryks M; Rhoten D; Burton D; Szarka LA; Acosta A; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13298. PubMed ID: 29405492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study.
    Gonenne J; Camilleri M; Ferber I; Burton D; Baxter K; Keyashian K; Foss J; Wallin B; Du W; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2005 Aug; 3(8):784-91. PubMed ID: 16234007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine.
    Boscan P; Van Hoogmoed LM; Pypendop BH; Farver TB; Snyder JR
    Am J Vet Res; 2006 Jun; 67(6):998-1004. PubMed ID: 16740093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
    Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
    J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
    Yuan CS; Wei G; Foss JF; O'Connor M; Karrison T; Osinski J
    J Pharmacol Exp Ther; 2002 Jan; 300(1):118-23. PubMed ID: 11752106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylnaltrexone on guinea pig gastrointestinal motility.
    Anselmi L; Huynh J; Vegezzi G; Sternini C
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Apr; 386(4):279-86. PubMed ID: 23361094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
    Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methylnaltrexone and naloxone on esophageal motor function in man.
    Scarpellini E; Pauwels A; Vos R; Rommel N; Tack J
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 28110513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [News from the cochrane library: mu opioid antagonists for opioid-induced bowel dysfunction].
    Meerpohl JJ; Timmer A
    Z Gastroenterol; 2008 Sep; 46(9):917-21. PubMed ID: 18810678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
    Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
    Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
    Merchan C; Altshuler D; Papadopoulos J
    Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans.
    Jeong ID; Camilleri M; Shin A; Iturrino J; Boldingh A; Busciglio I; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Aliment Pharmacol Ther; 2012 May; 35(9):1088-96. PubMed ID: 22348605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.
    Janku F; Johnson LK; Karp DD; Atkins JT; Singleton PA; Moss J
    Ann Oncol; 2016 Nov; 27(11):2032-2038. PubMed ID: 27573565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial.
    Paech M; Sng B; Ng L; Nathan E; Sia A; Carvalho B
    Br J Anaesth; 2015 Mar; 114(3):469-76. PubMed ID: 25567476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; O'Connor M; Karrison T; Osinski J; Roizen MF; Moss J
    Clin Pharmacol Ther; 2000 Apr; 67(4):398-404. PubMed ID: 10801249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ
    Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.